Viewing Study NCT06921850


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-29 @ 2:59 PM
Study NCT ID: NCT06921850
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-04-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module